These class actions allege that the drug makers engaged in misleading marketing campaigns, failed to provide adequate warnings, and ignored growing concerns raised in medical literature and post-marketing surveillance about serious side effects, including gastrointestinal disorders, cyclic vomiting syndrome, and sudden vision loss
Both use the active ingredient semaglutide, but they are not marketed for the same primary purpose
Pancreatic infections are potentially life-threatening and require immediate medical treatment
Its not only causing me stress, but it is making me angry. Starting Tuesday, CVS Caremark a major pharmacy benefit manager that serves as a middleman for health insurers, large employers and other payers to manage their prescription drug plans will stop covering Eli Lillys Zepbound, a blockbuster GLP-1 drug that has been approved by the US Food and Drug Administration since November 2023 for chronic weight management in adults with obesity or who are overweight
Compounded versions in pill form or mixed with other ingredients havent undergone rigorous trials